Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer

SIMPLE SUMMARY: Radiofrequency ablation (RFA) is a favorite treatment approach for patients with liver cancer, one of the most common malignancies worldwide. However, incomplete RFA often occurs in irregular and medium-to-larger (>3 cm) hepatic tumors. The aim of this study was to validate the fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guanhui, Kan, Xuefeng, Zhang, Feng, Ji, Hongxiu, Sun, Junhui, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777024/
https://www.ncbi.nlm.nih.gov/pubmed/36551579
http://dx.doi.org/10.3390/cancers14246093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777024/
https://www.ncbi.nlm.nih.gov/pubmed/36551579
http://dx.doi.org/10.3390/cancers14246093

Ejemplares similares